Table 1.
Code | Region | GC-MS or LC-MS | Total number of compounds | Number of compounds | Self-reported workflow | |||
---|---|---|---|---|---|---|---|---|
LC-MS | GC-MS | Target (%) | Suspect (%) | Nontarget (%) | ||||
Lab 1 | Asia-Pacific, N. America | Both | 591 | 457 | 134 | 6 | 5 | 89 |
Lab 2 | Europe | Both | 583 | 49 | 534 | 2 | 6 | 92 |
Lab 3 | Asia-Pacific, N. America | GC-MS | 525 | – | 525 | 0 | 0 | 100 |
Lab 4 | Asia-Pacific, N. America | Both | 417 | 271 | 146 | 15 | 14 | 78 |
Lab 5 | Europe | Both | 415 | 293 | 122 | 0 | 2 | 98 |
Lab 6 | Europe | LC-MS | 337 | 337 | – | 25 | 75 | 0 |
Lab 7 | Europe | Both | 287 | 57 | 230 | 1 | 11 | 88 |
Lab 8 | Asia-Pacific, N. America | Both | 216 | 25 | 191 | 29 | 19 | 52 |
Lab 9 | Europe | Both | 211 | 28 | 183 | 15 | 11 | 74 |
Lab 10 | Europe | Both | 122 | 77 | 45 | 19 | 26 | 55 |
Lab 11 | Asia-Pacific, N. America | LC-MS | 121 | 121 | – | 0 | 0 | 100 |
Lab 12 | Europe | LC-MS | 186 | 186 | – | 3 | 0 | 97 |
Lab 13 | Europe | Both | 180 | 143 | 37 | 0 | 0 | 100 |
Lab 14 | Europe | LC-MS | 77 | 77 | – | 0 | 58 | 42 |
Lab 15 | Europe | LC-MS | 69 | 69 | – | 38 | 48 | 14 |
Lab 16 | Europe | Both | 68 | 21 | 47 | 22 | 1 | 76 |
Lab 17 | Europe | Both | 57 | 46 | 11 | 91 | 0 | 9 |
Lab 18 | Asia-Pacific, N. America | Both | 55 | 29 | 26 | 100 | 0 | 0 |
Lab 19 | Europe | LC-MS | 40 | 40 | – | 0 | 0 | 100 |
Lab 20 | Asia-Pacific, N. America | Both | 23 | 12 | 11 | 4 | 9 | 87 |